D4Wsu53e Inhibitors
Rsrp1, involved in cellular regulation, can be modulated by various inhibitors targeting distinct pathways. Idasanutlin and Nutlin-3, MDM2 inhibitors, stabilize p53, indirectly influencing Rsrp1 by altering p53-mediated processes. BI-2536 and BI-6727 (Volasertib), targeting PLK1, impact mitotic processes, indirectly affecting Rsrp1 and cellular regulation. RO-3306 and MLN8054, inhibitors of CDK1 and Aurora A kinase, respectively, alter cell cycle progression and mitotic processes, influencing Rsrp1 activity. Pifithrin-α, a p53 inhibitor, modulates p53 transcriptional activity, indirectly impacting Rsrp1.
RITA, an activator of p53, influences Rsrp1 by activating the p53 pathway. ZM 447439 and GSK461364, targeting Aurora B kinase and PLK1, respectively, affect mitotic processes, indirectly influencing Rsrp1. Tenovin-6, inhibiting SIRT1 and SIRT2, alters sirtuin-mediated processes, indirectly impacting Rsrp1. NSC 663284, a Cdc2-like kinase (CLK) inhibitor, influences cell cycle progression, indirectly affecting Rsrp1 and cellular regulation. This diverse set of inhibitors offers potential avenues for exploring the modulation of Rsrp1 and understanding its role in cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BI 2536 | 755038-02-9 | sc-364431 sc-364431A | 5 mg 50 mg | $151.00 $525.00 | 8 | |
BI-2536, a PLK1 inhibitor, directly targets polo-like kinase 1. Its impact on cell cycle progression indirectly influences Rsrp1, affecting cellular regulation through modulation of mitotic processes. | ||||||
(+)-Nutlin-3 | 675576-97-3 | sc-222085 sc-222085A | 500 µg 1 mg | $94.00 $122.00 | ||
Nutlin-3, an MDM2 inhibitor, disrupts the MDM2-p53 interaction, stabilizing p53. Its influence on the p53 pathway indirectly impacts Rsrp1, altering cellular regulation through modulation of p53-mediated processes. | ||||||
RO-3306 | 872573-93-8 | sc-358700 sc-358700A sc-358700B | 1 mg 5 mg 25 mg | $66.00 $163.00 $326.00 | 37 | |
RO-3306, a CDK1 inhibitor, directly targets cyclin-dependent kinase 1. Its impact on cell cycle progression indirectly influences Rsrp1, affecting cellular regulation through modulation of mitotic processes. | ||||||
Pifithrin-α hydrobromide | 63208-82-2 | sc-45050 sc-45050A | 5 mg 25 mg | $120.00 $300.00 | 36 | |
Pifithrin-α(HBr), a p53 inhibitor, directly interferes with p53 transcriptional activity. By inhibiting p53, Pifithrin-α indirectly influences Rsrp1, altering cellular regulation through modulation of the p53 pathway. | ||||||
MLN 8054 | 869363-13-3 | sc-484828 | 5 mg | $398.00 | ||
MLN8054, an Aurora A kinase inhibitor, directly targets Aurora A kinase. Its impact on mitotic processes indirectly influences Rsrp1, altering cellular regulation through modulation of mitosis. | ||||||
p53 Activator III, RITA | 213261-59-7 | sc-202753 sc-202753A sc-202753B sc-202753C | 1 mg 10 mg 100 mg 500 mg | $112.00 $273.00 $1564.00 $5205.00 | 9 | |
RITA, a p53 activator, directly activates p53. Its influence on the p53 pathway indirectly impacts Rsrp1, altering cellular regulation through modulation of p53-mediated processes. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM 447439, an Aurora B kinase inhibitor, directly targets Aurora B kinase. Its impact on mitotic processes indirectly influences Rsrp1, affecting cellular regulation through modulation of mitosis. | ||||||
Tenovin-6 | 1011557-82-6 | sc-224296 sc-224296A | 1 mg 5 mg | $272.00 $1214.00 | 9 | |
Tenovin-6, an SIRT1 and SIRT2 inhibitor, directly targets SIRT1 and SIRT2. Its influence on sirtuin activity indirectly impacts Rsrp1, altering cellular regulation through modulation of sirtuin-mediated processes. | ||||||
GSK461364 | 929095-18-1 | sc-364504 sc-364504A | 10 mg 50 mg | $500.00 $1540.00 | ||
GSK461364, a PLK1 inhibitor, directly targets polo-like kinase 1. Its impact on cell cycle progression indirectly influences Rsrp1, affecting cellular regulation through modulation of mitotic processes. | ||||||
CDC25 Phosphatase Inhibitor II, NSC 663284 | 383907-43-5 | sc-202987A sc-202987 sc-202987B sc-202987C | 1 mg 5 mg 10 mg 25 mg | $51.00 $241.00 $357.00 $663.00 | 4 | |
NSC 663284, a Cdc2-like kinase (CLK) inhibitor, directly targets CLK. Its impact on cell cycle progression indirectly influences Rsrp1, affecting cellular regulation through modulation of mitotic processes. | ||||||